9IE0 | pdb_00009ie0

Human Deoxyhypusine Synthase Fragment Screening Campaign - ligand VT00222


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free: 
    0.196 (Depositor), 0.203 (DCC) 
  • R-Value Work: 
    0.181 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 
    0.182 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Crystallographic fragment screening supports tool compound discovery and reveals conformational flexibility in human deoxyhypusine synthase.

Wilk, P.Wator-Wilk, E.Muszak, D.Kochanowski, P.Krojer, T.Grudnik, P.

(2026) Commun Chem 

  • DOI: https://doi.org/10.1038/s42004-026-01897-9
  • Primary Citation of Related Structures:  
    9ID1, 9ID2, 9ID3, 9ID4, 9ID5, 9ID6, 9ID7, 9ID8, 9ID9, 9IDA, 9IDB, 9IDC, 9IDD, 9IDE, 9IDF, 9IDG, 9IDH, 9IDI, 9IDJ, 9IDK, 9IDL, 9IDM, 9IDN, 9IDO, 9IDP, 9IDQ, 9IDR, 9IDS, 9IDT, 9IDU, 9IDV, 9IDW, 9IDX, 9IDY, 9IDZ, 9IE0, 9IE1, 9IE2, 9IE3, 9IE4, 9IE5, 9IE6, 9IE7, 9IE8, 9IE9, 9IEA, 9IEB, 9IEC, 9IED, 9IEE

  • PubMed Abstract: 

    Deoxyhypusine synthase (DHS) catalyzes the rate-limiting step of hypusination, a unique post-translational modification of eukaryotic translation factor 5 A (eIF5A). While DHS activity plays a critical role in both normal cellular processes and disease development, the lack of specific molecular tools has hindered detailed studies of this enzyme and the hypusination pathway in general. Existing inhibitors, such as polyamine analogs, suffer from limited specificity and versatility. In this study, we utilized crystallographic fragment screening (CFS) to identify potential DHS inhibitors and explore novel applications of this approach. With an unprecedented hit rate of 39%, we identified fragment clusters binding at key sites, including the active site entrance, the tetramer interface, the regulatory ball-and-chain motif, and potentially allosteric regions on the enzyme's surface. Notably, we discovered a covalent modifier that targets the catalytic lysine residue in an oxidoreductase reaction-specific manner, as well as fragments that induce significant structural rearrangements of crucial regulatory elements. Our findings establish a framework for extending CFS beyond traditional inhibitor discovery, demonstrating its utility in probing protein dynamics, identifying novel binding pockets, and investigating regulatory mechanisms. These results offer new insights into DHS function, hypusination dynamics, and the broader methodological advancements that CFS contributes to structural biology and protein regulation research.


  • Organizational Affiliation
    • Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Deoxyhypusine synthase
A, B
369Homo sapiensMutation(s): 0 
Gene Names: DHPSDS
EC: 2.5.1.46
UniProt & NIH Common Fund Data Resources
Find proteins for P49366 (Homo sapiens)
Explore P49366 
Go to UniProtKB:  P49366
PHAROS:  P49366
GTEx:  ENSG00000095059 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP49366
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free:  0.196 (Depositor), 0.203 (DCC) 
  • R-Value Work:  0.181 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 0.182 (Depositor) 
Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 105.263α = 90
b = 105.263β = 90
c = 160.936γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata scaling
DIMPLEphasing
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Polish National Science CentrePolandUMO-2019/33/B/NZ1/01839
Polish National Science CentrePolandUMO-2022/47/B/NZ7/01667

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-21
    Type: Initial release
  • Version 1.1: 2026-01-28
    Changes: Database references